Who makes Tianeptine Sodium?

Tianeptine Sodium is developed by Jonathan A. Javitch, MD, PhD.

What development phase is Tianeptine Sodium in?

Tianeptine Sodium is FDA-approved (marketed).

Last reviewed 2026-04-20 · How we verify

Tianeptine Sodium

Jonathan A. Javitch, MD, PhD · FDA-approved active Small molecule Quality 2/100

At a glance

Generic name	Tianeptine Sodium
Also known as	Tianeurex 12.5 mg
Sponsor	Jonathan A. Javitch, MD, PhD
Modality	Small molecule
Phase	FDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Tianeptine for Treatment Resistant Depression (PHASE4)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Tianeptine Sodium CI brief — competitive landscape report
Tianeptine Sodium updates RSS · CI watch RSS
Jonathan A. Javitch, MD, PhD portfolio CI